Findings
adenomyosis pain, pain
ADVERSE EVENTS, SECONDARY
In this randomized clinical trial of 134 participants with adenomyosis pain symptoms, the participants in the mifepristone group and had significantly greater improvement in pain scores than the placebo group. All the secondary outcomes, including hemoglobin, platelet count, and uterine volume, showed significant improvements in the mifepristone group, and there were no serious adverse events.